The pet industry has grown impressively over the past year as more people adopted pets given their remote lifestyles, thereby increasing aggregate expenditure on pet nutrition, medications, diagnostic devices and other products. Because the pet-ownership trend is likely to continue amid the hybrid working structure now embraced by many businesses, various companies have been developing new drugs or solutions for advanced pet care. Against this backdrop, we believe popular pet care companies Zoetis (ZTS) and Elanco Animal (ELAN) are well-positioned to capitalize on the industry tailwinds. But let’s find out which of these stocks is a better buy now. Zoetis Inc . (NYSE:ZTS) discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. The company provides its services through five categories, namely anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals.
Elanco Animal Health Incorporated (NYSE:ELAN) is an animal health care company that develops, manufactures, and markets products for companion and food animals. The company sells its products to third-party distributors, veterinarians, and farm animal producers, and dairy farmers, and provides aquaculture operations.
Remote lifestyles gave rise to increased pet adoption during the worst of the COVID-19 pandemic. Consequently, huge spending on pet toys, nutrition, etc. led to all-time high pet industry sales of $103.60 billion in 2020, up 6.7% year-over-year, according to a report published by American Pet Products Association.